Literature DB >> 16904193

Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.

Catherine Weir1, Andrea McNeill, Sarah Hook, Marina Harvie, Anne Camille La Flamme, Graham Le Gros, B Thomas Bäckström.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an organ-specific autoimmune disease model used to investigate mechanisms involved in the activation of self-reactive T cells. Preproenkephalin (PPNK) is the gene that encodes the protein proenkephalin A that has been detected in the brain, adrenal cells and cells of the immune system. In this paper, whether PPNK plays a role in the development of EAE was investigated. PPNK-deficient and wild-type mice were immunized with the MOG(35-55) peptide and the development of EAE observed. Our results show that PPNK-deficient mice developed less severe clinical signs of disease than wild-type mice, and with lower incidence. MOG(35-55)-specific T cells from PPNK-deficient and wild-type mice produced IFNgamma and TNFalpha but no IL-4 or IL-10, indicative of a Th1 phenotype. However, the numbers of MOG(35-55)-specific IFNgamma-producing cells from immunized PPNK-deficient mice were largely reduced at early stages of disease. Interestingly, there was no difference in clinical signs or infiltrating mononuclear cells in the CNS between wild-type and PPNK-deficient mice at the later stage of disease. Our results suggest that PPNK accelerates the generation of autoimmune IFNgamma-producing T cells and MOG(35-55)-induced EAE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904193     DOI: 10.1016/j.jneuroim.2006.06.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.

Authors:  Patricia J McLaughlin; Daniel P McHugh; Marcus J Magister; Ian S Zagon
Journal:  BMC Immunol       Date:  2015-04-24       Impact factor: 3.615

3.  Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis.

Authors:  Madeleine White; Gill Webster; David O'Sullivan; Sarrabeth Stone; Anne Camille La Flamme
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

4.  Killing effect of methionine enkephalin on melanoma in vivo and in vitro.

Authors:  Dong-Mei Wang; Xue Jiao; Nicolas P Plotnikoff; Noreen Griffin; Rui-Qun Qi; Xing-Hua Gao; Feng-Ping Shan
Journal:  Oncol Rep       Date:  2017-08-24       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.